Teva's Latest ANDA Draws Fire

Law360, New York (January 19, 2006, 12:00 AM EST) -- A Japanese pharmaceutical giant has slapped Israeli generic drug maker Teva Pharmaceuticals Industries Ltd. with a patent infringement lawsuit in a battle over Prevacid, a drug used to treat acid reflux.

Takeda Pharmaceuticals Company filed suit in U.S. District Court for the District of Delaware earlier this week, asserting that Teva had illegally challenged its patents connected to the brand name drug.

Takeda was joined in the lawsuit by the exclusive licensee of the technology, TAP Pharmaceuticals, which holds the New Drug Application for lansoprazole delayed...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.